序号 |
标题 |
次数 |
作者 |
发布时间 |
72676 |
cas:886209-60-5,perfluorophenyl 2-(cyclooct-2-ynyloxy)acetate |
93 |
zyl |
2024-12-23 |
72677 |
DOOCCH2CH2COOD烷基链试剂 |
97 |
h |
2024-12-23 |
72678 |
cas:1092654-47-1,Azido-PEG3-CH2CO2-NHS |
79 |
wyh |
2024-12-23 |
72679 |
N-芴甲氧羰基-五聚乙二醇-乙酸,Fmoc-NH-PEG5-CH2COOH |
90 |
wyh |
2024-12-23 |
72680 |
cas:1232769-29-7,Mal-CO-PEG5-NHS ester |
117 |
zyl |
2024-12-23 |
72681 |
氨基-PEG4-丁酸,Amino-PEG4-(CH2)3CO2H |
95 |
wyh |
2024-12-23 |
72682 |
cas:1342211-31-7, MC-Val-Ala-OH |
79 |
zyl |
2024-12-23 |
72683 |
cas:150244‐18‐1,sulfo-LC-SPDP |
126 |
zyl |
2024-12-23 |
72684 |
Azido-PEG3-CH2CO2Me,叠氮-三聚乙二醇-CH2CO2甲基 |
140 |
wyh |
2024-12-23 |
72685 |
cas:663598-89-8,1-(4-((5-nitropyridin-2-yl)disulfanyl)butanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid |
105 |
zyl |
2024-12-23 |
72686 |
99mTc-HYNIC-PEG4-E[PEG4-c(RGDfk)]2(即99mTc-3PRGD2) |
137 |
wyh |
2024-12-23 |
72687 |
cas:121115-30-8 SPDP-sulfo 2,5-dioxo-1-(3-(pyridin-2-yldisulfanyl)propanoyloxy)pyrrolidine-3-sulfonic acid |
124 |
zyl |
2024-12-23 |
72688 |
MP-PEG8-Val-Ala-PAB-(imp)PBD的组成部分 |
110 |
wyh |
2024-12-23 |
72689 |
perfluorophenyl 3-(2-(2-(2-(1,3-dioxoisoindolin-2-yloxy)ethoxy)ethoxy)ethoxy)propanoate |
133 |
zyl |
2024-12-23 |
72690 |
MC-Val-Cit-PABC-BF211,抗体药物偶联物(ADCs) |
120 |
wyh |
2024-12-23 |
72691 |
2,3,4,5,6-pentafluorophenyl 3-[2-(2-{2-[(4-formylphenyl)formamido]ethoxy}ethoxy)ethoxy]propanoate |
76 |
zyl |
2024-12-23 |
72692 |
DOPG:DOPC Liposomes,磷脂酰甘油与磷脂酰胆碱脂质体 |
215 |
axc |
2024-12-23 |
72693 |
cas:1353012-00-6,perfluorophenyl 1-azido-3,6,9,12-tetraoxapentadecan-15-oate |
101 |
zyl |
2024-12-23 |
72694 |
1V209-PEG23-TA , 4,7,10-三氧杂-1,13-十三烷二胺和α-甘露糖 |
139 |
wyh |
2024-12-23 |
72695 |
cas:943858-70-6,Azidobutyric acid NHS ester |
96 |
zyl |
2024-12-23 |
72696 |
DOPG Liposomes,磷脂酰甘油脂质体 |
100 |
axc |
2024-12-23 |
72697 |
(64)Cu-NOTA-PEG4-LLP2A的结构组成 |
81 |
wyh |
2024-12-23 |
72698 |
99mTc(CO)3-DPA-DBCO-PEG4-CTT-54的显像效果 |
139 |
wyh |
2024-12-23 |
72699 |
DOPS:DOPC Liposomes,磷脂酰丝氨酸与磷脂酰胆碱脂质体 |
251 |
axc |
2024-12-23 |
72700 |
2,5-dioxopyrrolidin-1-yl 11-oxo-4,7,13-trioxa-10-azahexadec-15-yn-1-oate |
104 |
zyl |
2024-12-23 |
72701 |
DOPC Liposomes,二油酰磷脂酰胆碱脂质体 |
158 |
axc |
2024-12-23 |
72702 |
DTPA(Gd)-PEG8-(FY)3的结构特点 |
94 |
wyh |
2024-12-23 |
72703 |
Fucα1-2Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
94 |
h |
2024-12-23 |
72704 |
DSPC Liposomes,二硬脂酰磷脂酰胆碱脂质体 |
144 |
axc |
2024-12-23 |
72705 |
GlcNAcβ1-3Galβ1-4Glc-O-(CH2)3-NH-Lipoic |
108 |
h |
2024-12-23 |
72706 |
HSPC Liposomes,氢化大豆磷脂酰胆碱脂质体 |
264 |
axc |
2024-12-23 |
72707 |
cas:80307-12-6,GMBS,N-(4-马来酰亚胺丁酰基)琥珀酰亚胺 |
165 |
zyl |
2024-12-23 |
72708 |
DMPC Liposomes,二肉豆蔻酰磷脂酰胆碱脂质体 |
191 |
axc |
2024-12-23 |
72709 |
Galβ1-4GlcNAcβ1-3Gal-O-(CH2)3-NH-DBCO 含DBCO的核心2型丙糖(接头-DBCO A) |
131 |
h |
2024-12-23 |
72710 |
DSPC:Chol Liposomes,二硬脂酰磷脂酰胆碱-胆固醇脂质体 |
334 |
axc |
2024-12-23 |
72711 |
Galβ1-3GlcNAcβ1-3Gal-O-(CH2)3-NH-CS-NH-Fluorescein |
155 |
h |
2024-12-23 |
72712 |
HSPC:Chol Liposomes,磷脂酰丝氨酸-胆固醇脂质体 |
385 |
axc |
2024-12-23 |
72713 |
Glcα1-4[Glcα1-4]8Glc-O-(CH2)3-NH-CS-NH-Fluorescein |
111 |
h |
2024-12-23 |
72714 |
DMPC:Chol Liposomes,二肉豆蔻酰磷脂酰胆碱-胆固醇脂质体 |
131 |
axc |
2024-12-23 |
72715 |
C34-PEG4-Chol ,胆固醇标记LA HIV融合抑制剂 |
125 |
wyh |
2024-12-23 |
72716 |
具有游离末端胺的麦芽酮糖DP9(接头-NH2 A) |
165 |
h |
2024-12-23 |
72717 |
DOPC:DSPE-mPEG2000 Liposomes,二油酰磷脂酰胆碱-聚乙二醇化二硬脂酰磷脂酰乙醇胺脂质体 |
259 |
axc |
2024-12-23 |
72718 |
氨基聚乙二醇十一酰胺,PEG-NHCO(CH2)11-NH2 |
85 |
wyh |
2024-12-23 |
72719 |
R(OTf)2Sn(CH2)8Sn(OTf)2CH2SiMe3的化学结构 |
101 |
wyh |
2024-12-23 |
72720 |
DSPC:DSPE-mPEG2000 Liposomes,二硬脂酰磷脂酰胆碱-聚乙二醇化二硬脂酰磷脂酰乙醇胺脂质体 |
165 |
axc |
2024-12-23 |